Latest Period
Q2 2026
Security Snapshot
Emergent BioSolutions Inc. - Common Stock (EBS) Institutional Ownership
CUSIP: 29089Q105
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
193
Shares (Excl. Options)
44,587,636
Price
$8.38
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- EBS on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 44,587,636
- Total 13F value
- $373,639,486
- Portfolio coverage rank
- 0%
- Share change
- +1,533,553
- Value change
- +$12,773,804
- Number of holders
- 193
- Shares outstanding
- 51,304,593
- SEC-reported price per share
- $7.26
- Insider filing price
- $7.26
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- EBS - Emergent BioSolutions Inc. - Common Stock is tracked under CUSIP 29089Q105.
- 193 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 189 to 193 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $360,677,212 to $373,639,486.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 193 institutions filings for Q2 2026.
Security key
29089Q105
Latest holder period
Q2 2026
13F holders
193
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
EBS full holder history
Emergent BioSolutions Inc. SEC filings
Emergent BioSolutions Inc. company facts
Emergent BioSolutions Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29089Q105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
EBS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 9% | +24% | $38,978,221 | +$5,646,478 | 4,651,339 | +17% | BlackRock, Inc. | 30 Jun 2026 |
| AMERICAN CENTURY INVESTMENT MANAGEMENT INC | 5.4% | $22,939,309 | 2,770,448 | American Century Investment Management, Inc. | 30 Jun 2026 | |||
| DIMENSIONAL FUND ADVISORS LP | 5.3% | $22,887,169 | 2,757,158 | Dimensional Fund Advisors LP | 31 Mar 2026 | |||
| STATE STREET CORP | 5.1% | $33,408,086 | 2,696,375 | STATE STREET CORPORATION | 31 Dec 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 4.9% | -2.4% | $21,039,025 | -$531,121 | 2,540,945 | -2.5% | Vanguard Capital Management | 30 Jun 2026 |
As of 30 Jun 2026, 193 institutional investors reported holding 44,587,636 shares of Emergent BioSolutions Inc. - Common Stock (EBS). This represents 87% of the company’s total 51,304,593 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.2% | 4,716,599 | +8.6% | 0% | $39,525,100 |
| DIMENSIONAL FUND ADVISORS LP | 6% | 3,076,646 | +12% | 0% | $25,782,865 |
| STATE STREET CORP | 5.7% | 2,929,238 | +2.8% | 0% | $24,556,367 |
| AMERICAN CENTURY COMPANIES INC | 5.4% | 2,770,448 | +14% | 0.01% | $23,216,354 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 2,198,839 | -2.6% | 0% | $18,426,271 |
| LSV ASSET MANAGEMENT | 3.3% | 1,695,851 | +89% | 0.03% | $14,211,000 |
| ACADIAN ASSET MANAGEMENT LLC | 2.6% | 1,344,323 | -2.7% | 0.01% | $11,258,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 1,337,243 | +5.1% | 0% | $11,208,910 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.3% | 1,200,791 | -20% | 0% | $10,062,629 |
| OAK HILL ADVISORS LP | 2.2% | 1,113,338 | 0% | 1.3% | $9,329,772 |
| MILLENNIUM MANAGEMENT LLC | 2.1% | 1,072,185 | +102% | 0.01% | $8,984,910 |
| Ancora Advisors LLC | 2.1% | 1,067,867 | +161% | 0.17% | $8,948,726 |
| AQR CAPITAL MANAGEMENT LLC | 2% | 1,041,151 | +5.2% | 0% | $8,724,846 |
| GOLDMAN SACHS GROUP INC | 2% | 1,035,421 | +28% | 0% | $8,676,828 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2% | 1,029,371 | -7.9% | 0% | $8,626,129 |
| D. E. Shaw & Co., Inc. | 1.8% | 900,108 | -10% | 0% | $7,542,905 |
| Russell Investments Group, Ltd. | 1.7% | 859,482 | +156% | 0.01% | $7,202,462 |
| FEDERATED HERMES, INC. | 1.6% | 831,125 | +82% | 0.01% | $6,964,828 |
| PRUDENTIAL FINANCIAL INC | 1.6% | 805,895 | +80% | 0.01% | $6,753,400 |
| Prescott Group Capital Management, L.L.C. | 1.5% | 772,771 | 0% | 0.56% | $6,475,821 |
| RENAISSANCE TECHNOLOGIES LLC | 1.3% | 683,247 | +4.1% | 0.01% | $5,725,610 |
| NORTHERN TRUST CORP | 1.2% | 621,473 | +3.4% | 0% | $5,207,944 |
| Allianz Asset Management GmbH | 1.1% | 543,781 | +16% | 0% | $4,556,885 |
| PALISADE CAPITAL MANAGEMENT, LP | 1% | 515,059 | -57% | 0.19% | $4,316,191 |
| NEW YORK STATE COMMON RETIREMENT FUND | 1% | 513,904 | 0% | 0.01% | $4,306,516 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 44,587,636 | $373,639,486 | +$12,773,804 | $8.38 | 193 |
| 2026 Q1 | 43,435,843 | $360,677,212 | -$7,337,939 | $8.30 | 189 |
| 2025 Q4 | 43,409,290 | $536,520,249 | +$24,748,817 | $12.36 | 182 |
| 2025 Q3 | 41,696,734 | $352,475,753 | +$19,667,092 | $8.82 | 167 |
| 2025 Q2 | 36,048,259 | $229,963,501 | +$8,627,423 | $6.38 | 159 |
| 2025 Q1 | 36,190,861 | $175,869,555 | +$2,175,881 | $4.86 | 158 |
| 2024 Q4 | 34,731,466 | $332,026,231 | +$28,116,282 | $9.56 | 155 |
| 2024 Q3 | 31,685,912 | $264,526,545 | +$30,958,222 | $8.35 | 137 |
| 2024 Q2 | 30,424,097 | $207,508,937 | -$26,587,800 | $6.82 | 137 |
| 2024 Q1 | 35,915,952 | $90,810,710 | -$12,044,764 | $2.53 | 115 |
| 2023 Q4 | 40,884,124 | $98,125,874 | -$3,033,553 | $2.40 | 129 |
| 2023 Q3 | 41,326,491 | $140,783,681 | -$26,266,322 | $3.40 | 159 |
| 2023 Q2 | 45,670,504 | $335,708,725 | +$1,389,547 | $7.35 | 177 |
| 2023 Q1 | 44,931,082 | $465,319,997 | -$16,940,760 | $10.36 | 187 |
| 2022 Q4 | 46,237,482 | $546,050,427 | +$42,157,405 | $11.81 | 193 |
| 2022 Q3 | 40,630,823 | $852,783,613 | -$48,608,549 | $20.99 | 192 |
| 2022 Q2 | 41,191,389 | $1,278,322,431 | -$19,204,360 | $31.04 | 217 |
| 2022 Q1 | 41,761,849 | $1,714,987,525 | -$22,633,768 | $41.06 | 234 |
| 2021 Q4 | 42,514,559 | $1,849,372,320 | -$107,864,716 | $43.47 | 243 |
| 2021 Q3 | 44,511,870 | $2,228,860,734 | -$18,391,350 | $50.07 | 270 |
| 2021 Q2 | 44,739,294 | $2,817,444,749 | -$43,662,628 | $62.99 | 286 |
| 2021 Q1 | 44,459,246 | $4,122,801,151 | +$64,719,540 | $92.91 | 334 |
| 2020 Q4 | 44,267,661 | $3,967,537,088 | +$93,758,805 | $89.60 | 350 |
| 2020 Q3 | 42,899,052 | $4,434,039,819 | -$189,544,769 | $103.33 | 355 |
| 2020 Q2 | 53,497,347 | $4,185,752,138 | +$625,343,109 | $79.08 | 295 |